Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10032


Purpose:

The study sought to assess the rate of recurrent stroke and death in stroke patients with a patent foramen ovale randomized to treatment with warfarin or aspirin. This was a multicenter study conducted at 48 U.S. Institutions.


Criteria:

Inclusion Criteria: - Age 30-85 - Ischemic stroke within 30 days - Glasgow outcome scale ≥ 3 - No contraindications to warfarin/aspirin Exclusion Criteria: - Basal INR > 1.4 - Post-procedural stroke - Severe carotid atherosclerosis - Cardioembolic stroke - Contraindications to transesophageal echocardiography


NCT ID:

NCT00697151


Primary Contact:

Principal Investigator
Shunichi Homma, MD
Columbia University


Backup Contact:

N/A


Location Contact:

New York, New York 10032
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.